TX2100 / Tectonic Therap - LARVOL DELTA

Tectonic Announces $185 Million Private Placement (GlobeNewswire) - "Tectonic Therapeutic, Inc...today announced that it has entered into a securities purchase agreement for a private investment in public equity financing (the 'PIPE') that is expected to result in gross proceeds of approximately $185.0 million...Tectonic expects to use net proceeds from the PIPE to fund the clinical development of TX45, clinical development of TX2100, discovery platform development as well as for working capital and other general corporate purposes. The PIPE is expected to close on February 5, 2025, subject to the satisfaction of customary closing conditions."

Financing • Cardiovascular • Respiratory Diseases